Rituximab as a Treatment for Non Hodgkin’s Lymphoma LIB 100, M11 Avalon Adams Professor Khan Spring 2014

Topic: Rituximab as a Treatment for Non Hodgkin’s Lymphoma

Thesis: Rituximab is a medication, when used helps fights off cancer and tries to restore the normal cycle of a lymphocyte.
Selection and Evaluation of Sources: For my first source I used the entry on New developments in the management of diffuse large B cell Lymphoma written by Thomas M. Habermann. I found this article by searching the EBSCO Academic Search Premier database. The article is current because it was published in 2012. It is authoritative because the author Habermann is affiliated with the Mayo Clinic Rochester, MN 55905, USA. For my second source I used an article, Rituximab in the treatment of Non Hodgkin’s Lymphoma by Beate Hauptrock and George Hess in the journal PMC US National Library of Medicine National Institutes of Health. I found this article by searching the The National Center for Biotechnology Information. The article is current because it was published online Dec 2008. It is authoritative because Hauptrock and Hess are both researchers at the Hematology/Oncology Department , Johannes Gutenberg-University, Mainz, Germany. For my third source I used an article, Immunotherapy for non-Hodgkin lymphoma written by the staff of the American Cancer Society. I found this article by searching the American Cancer Society website. The article is current because it was last revised on November 14, 2013. It is an authoritative because the American Cancer Society is a nationwide, community-based voluntary health organization dedicated to eliminating cancer as a major health problem. References

American Cancer Society Staff. (2013). Immunotherapy for Non-Hodgkin